16,095 Shares in Omega Healthcare Investors, Inc. (NYSE:OHI) Bought by Quantbot Technologies LP

Quantbot Technologies LP bought a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 16,095 shares of the real estate investment trust’s stock, valued at approximately $609,000.

Other institutional investors also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Omega Healthcare Investors by 328.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after acquiring an additional 1,274,238 shares during the last quarter. Daiwa Securities Group Inc. grew its holdings in Omega Healthcare Investors by 22.6% during the fourth quarter. Daiwa Securities Group Inc. now owns 4,840,280 shares of the real estate investment trust’s stock valued at $183,205,000 after purchasing an additional 890,912 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Omega Healthcare Investors in the fourth quarter valued at approximately $20,058,000. FMR LLC lifted its stake in shares of Omega Healthcare Investors by 9.9% in the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares during the last quarter. Finally, Franklin Resources Inc. boosted its holdings in shares of Omega Healthcare Investors by 441.4% during the 3rd quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock worth $17,177,000 after buying an additional 350,570 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI opened at $37.50 on Friday. The firm has a market capitalization of $10.57 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 1.09 and a beta of 1.00. Omega Healthcare Investors, Inc. has a one year low of $29.66 and a one year high of $44.42. The business has a fifty day simple moving average of $37.10 and a 200 day simple moving average of $38.83. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. Sell-side analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 7.15%. The ex-dividend date was Monday, February 10th. Omega Healthcare Investors’s payout ratio is 172.90%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. BMO Capital Markets raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price for the company in a research report on Monday, December 9th. Truist Financial boosted their price objective on Omega Healthcare Investors from $38.00 to $39.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Mizuho raised their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. JMP Securities reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Finally, Wells Fargo & Company cut Omega Healthcare Investors from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $41.00 to $39.00 in a research report on Thursday. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $42.00.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.